oligo
synthesi
long
histori
begin
academ
lab
follow
autom
commerci
progress
highthroughput
arraybas
method
histori
extens
review
mostli
cover
current
approach
understand
advantag
tradeoff
effect
downstream
gene
synthesi
process
columnbas
oligo
synthesi
first
synthet
oligo
report
todd
khorana
cowork
use
phosphodiest
hphosphon
phosphotriest
approach
today
domin
chemistri
oligo
synthesi
occur
autom
instrument
employ
solidphas
phosphoramidit
chemistri
first
develop
marvin
caruth
fig
phosphoramiditebas
oligo
synthesi
commonli
consist
fourstep
cycl
add
base
one
time
grow
oligo
chain
attach
solid
support
first
dimethoxytrityl
dmt
protect
nucleosid
phosphoramidit
attach
solid
support
deprotect
remov
dmt
use
trichloroacet
acid
second
new
dmtprotect
phosphoramidit
coupl
hydroxyl
group
grow
oligo
chain
form
phosphit
triester
third
cap
step
acetyl
remain
unreact
hydroxyl
group
make
unreact
oligo
chain
inert
nucleosid
addit
help
allevi
delet
error
fourth
iodin
oxid
convert
phosphit
phosphat
produc
cyanoethylprotect
phosphat
backbon
dmt
protect
group
remov
allow
cycl
continu
detrityl
step
usual
monitor
track
coupl
effici
individu
base
ad
nucleosid
ad
seri
complet
oligo
remov
solid
support
protect
group
base
phosphat
backbon
remov
autom
process
usual
synthes
oligo
simultan
scale
nmol
year
improv
raw
materi
autom
process
purif
enabl
routin
synthesi
dna
predomin
inform
carrier
life
develop
synthet
techniqu
construct
dna
led
mark
improv
abil
understand
engin
biolog
exampl
despit
extens
effort
unravel
genet
code
use
molecular
genet
modest
capabl
synthes
nucleic
acid
ultim
led
code
unravel
today
reconstruct
complet
viral
bacteri
genom
testament
far
synthet
capabl
come
despit
improv
abil
read
dna
better
abil
write
last
decad
highthroughput
sequenc
technolog
refer
nextgener
sequenc
ng
revolution
discoveri
understand
natur
dna
sequenc
current
instal
capac
estim
petabas
per
year
largescal
datashar
initi
genbank
continu
improv
bioinformat
softwar
made
comput
analys
data
easier
ever
analys
help
gener
power
statist
hypothes
genom
sequenc
control
cellular
function
across
organ
popul
addit
ngsbase
measur
tool
allow
analysi
mani
genet
biochem
process
unpreced
scale
low
cost
howev
even
though
abil
gener
hypothes
measur
outcom
increas
scale
owe
ng
abil
test
hypothes
experiment
still
lag
among
limit
step
studi
natur
engin
biolog
year
synthet
product
new
dna
sequenc
help
research
understand
engin
biolog
summar
method
caveat
de
novo
synthesi
dna
particular
emphasi
recent
technolog
allow
largescal
lowcost
product
addit
discuss
emerg
applic
enabl
largescal
de
novo
dna
construct
well
challeng
opportun
lie
ahead
specif
design
dna
construct
physic
instanc
hypothesi
test
whether
simpl
plasmidbas
report
wholegenom
synthesi
organ
progress
largescal
lowcost
construct
desir
dna
sequenc
could
rapidli
engend
progress
fundament
appli
biolog
research
although
rapid
modif
natur
dna
sequenc
vitro
vivo
use
varieti
purpos
methodolog
de
novo
synthesi
dna
nucleosid
confer
number
uniqu
advantag
first
engin
new
function
often
requir
vastli
modifi
wholli
new
genet
sequenc
easili
access
de
novo
synthesi
methodolog
second
synthes
construct
often
superior
natur
sequenc
studi
genet
mechan
design
specif
test
hypothes
sequenc
affect
function
final
sequenc
target
amplifi
modifi
natur
sequenc
difficult
access
exampl
metagenom
data
set
thu
synthesi
practic
way
experiment
studi
review
technolog
innov
applic
de
novo
dna
synthesi
distinct
assembl
modif
natur
dna
sequenc
cover
largescal
singlestrand
dna
oligonucleotid
oligo
synthesi
assembl
oligo
longer
doublestrand
dna
construct
emerg
applic
fig
nt
cost
per
nucleotid
error
rate
nt
better
limit
length
error
rate
process
due
major
reason
first
yield
step
synthet
cycl
must
high
especi
product
long
oligo
exampl
even
yield
turn
cycl
result
final
yield
oligo
synthesi
addit
depurin
particularli
adenosin
occur
acid
detrityl
becom
particularli
problemat
product
long
oligo
final
remov
protect
group
base
phosphat
backbon
abas
site
lead
cleavag
reduc
yield
longlength
oligo
final
even
success
synthes
oligo
contain
appreci
error
domin
error
purifi
oligo
singlebas
delet
result
either
failur
remov
dmt
combin
ineffici
coupl
cap
step
newer
chemistri
improv
process
continu
aris
augment
oligo
length
qualiti
arraybas
oligo
synthesi
start
earli
affymetrix
develop
method
spatial
local
polym
synthesi
surfac
use
lightactiv
chemistri
pave
way
develop
dna
microarray
use
standard
maskbas
photolithograph
techniqu
select
deprotect
photolabil
nucleosid
phosphoramidit
today
sever
technolog
coexist
make
spatial
decoupl
dna
microarray
maskless
procedur
use
exampl
nimblegen
lc
scienc
greatli
simplifi
photolithograph
techniqu
use
programm
micromirror
devicessimilar
found
modernday
digit
projectorsto
direct
lightbas
chemistri
inkjetbas
print
nucleotid
array
surfac
agil
use
allow
oligo
synthesi
use
standard
phosphoramidit
chemistri
addit
combimatrix
customarray
develop
semiconductorbas
electrochem
acid
product
select
deprotect
nucleosid
mani
promis
extens
variat
microfluid
microarray
synthes
report
kosuri
et
al
step
deprotect
acidcatalyz
remov
dmt
allow
subsequ
base
addit
step
base
coupl
dmtprotect
phosphoramidit
ad
unprotect
oh
use
tetrazol
activ
step
cap
option
unreact
oh
acetyl
prevent
chain
extens
step
help
prevent
singlebas
delet
expens
yield
step
oxid
oxid
phosphit
triester
phosphat
use
aqueou
iodin
yet
becom
wide
avail
commerci
use
microarrayderiv
oligo
wherebi
oligo
synthes
array
cleav
harvest
one
oligo
pool
becom
increasingli
popular
cheap
sourc
design
oligo
scale
length
error
rate
vari
greatli
vendor
date
agil
technolog
customarray
provid
oligo
use
recent
public
see
emerg
applic
larg
de
novo
dna
synthesi
oligo
produc
microarray
order
magnitud
cheaper
columnbas
oligo
cost
rang
per
nucleotid
depend
length
scale
platform
small
set
oligo
usual
oligo
provid
raw
substrat
construct
larger
synthet
fragment
usual
bp
via
varieti
method
collect
term
gene
synthesi
gene
refer
gene
length
rather
classic
genet
definit
first
synthet
gene
short
bp
gobind
khorana
group
use
dna
ligas
seal
chemic
synthes
oligo
togeth
ligationbas
approach
complementari
overlap
strand
enzymat
join
produc
larger
fragment
initi
done
sequenti
higherqu
oligo
use
thermost
ligas
improv
hybrid
stringenc
method
produc
select
circular
dna
allow
onepot
product
genelength
fragment
polymeras
cycl
assembl
pca
base
techniqu
use
polymeras
extend
overlap
oligo
doublestrand
fragment
cycl
nonexponenti
process
ligat
pca
approach
usual
reli
pcr
isol
amplifi
fulllength
partial
assembl
fragment
often
use
combin
recent
gibson
colleagu
develop
vivo
vitro
onestep
protocol
assembl
clone
oligo
directli
plasmid
backbon
protocol
iter
improv
underli
academ
commerci
gene
synthesi
effort
review
elsewher
final
oligo
synthesi
assembl
techniqu
prone
error
genelength
fragment
often
clone
sequenc
verifi
substanti
add
final
cost
advantag
disadvantag
approach
highstring
ligationbas
synthes
reduc
error
rate
sequenc
error
less
like
hybrid
ligat
howev
top
bottom
strand
need
synthes
oligo
requir
phosphoryl
end
oligo
cost
higher
pcabas
approach
reli
overlap
region
nt
thu
allow
fewer
oligo
per
gene
synthes
suffer
higher
error
rate
owe
lack
hybridizationbas
error
filtrat
also
pcabas
approach
contain
region
encod
singl
oligo
target
divers
introduc
locat
method
sequenc
contain
high
gc
content
secondari
structur
inhibit
assembl
owe
misann
loss
ligat
stringenc
also
pcr
use
final
step
amplifi
construct
partial
assembl
length
synthet
gene
gener
method
usual
kept
kb
reliabl
better
assembl
techniqu
exist
larger
assembl
see
arraybas
gene
synthesi
even
though
microarraybas
oligo
pool
cheap
sever
challeng
use
gene
synthesi
first
although
number
oligo
produc
pool
larg
individu
concentr
quit
low
exist
gene
synthesi
protocol
second
error
rate
oligo
pool
usual
higher
columnsynthes
oligo
final
sheer
number
oligo
produc
lead
interfer
gene
assembl
make
difficult
scale
tian
et
al
first
show
problem
could
overcom
use
pcr
amplif
increas
concentr
oligo
assembl
errorcorrect
hybrid
revers
complementari
oligo
also
construct
chip
design
protein
sequenc
comput
avoid
potenti
mishybrid
sequenc
howev
work
contemporan
report
use
dozen
hundr
oligo
scale
method
prove
difficult
beyond
pool
size
oligo
greater
pool
complex
advantag
cost
would
come
play
construct
individu
gene
becam
difficult
presum
owe
spuriou
crosshybrid
assembl
process
addit
method
requir
suffici
sequenc
orthogon
synthes
gene
limit
potenti
applic
allevi
issu
two
approach
use
first
isol
subpool
oligo
requir
singl
assembl
therebi
overcom
concern
pool
complex
sequenc
orthogon
fig
kosuri
et
al
use
predesign
barcod
allow
pcr
amplif
oligo
particip
particular
assembl
remov
barcod
digest
follow
standard
assembl
gene
quan
et
al
use
custom
inkjet
synthes
synthes
subset
oligo
physic
separ
microwel
amplif
assembl
done
situ
method
use
much
larger
oligo
pool
oligo
enzymat
error
correct
pave
way
commerci
recent
year
final
two
report
use
onepot
assembl
librari
gene
directli
use
custom
synthes
print
oligo
need
assembl
separ
micropattern
well
leverag
spatial
separ
enabl
microarray
synthesi
amplifi
assembl
gene
within
microwel
npg
review
focu
synthet
biolog
larg
pool
attempt
limit
join
one
two
oligo
simultan
suffer
larg
differ
dynam
rang
inabl
make
sequenc
similar
one
anoth
clone
error
correct
verif
synthet
gene
assembl
contain
mixtur
perfect
imperfect
sequenc
result
oligo
synthesi
assembl
error
fig
usual
synthes
gene
clone
plasmid
escherichia
coli
yeast
sequenc
verifi
sanger
sequenc
step
expens
time
consum
difficult
autom
thu
reduc
number
clone
requir
get
perfect
sequenc
paramount
help
allevi
synthesi
error
earli
approach
fuse
synthet
proteincod
sequenc
frame
select
marker
encod
antibiot
resist
fluoresc
marker
singlebas
delet
like
result
frameshift
thu
loss
activ
serv
use
errorcorrect
method
limit
proteincod
sequenc
gener
method
error
correct
usual
depend
upon
number
enzymat
techniqu
reduc
error
techniqu
reli
fact
given
posit
molecul
possess
correct
base
heat
reanneal
forc
format
heteroduplex
contain
disrupt
canon
helic
dna
structur
disrupt
recogn
act
upon
sever
protein
mut
bind
heteroduplex
use
filter
error
revers
purif
certain
polymeras
exonucleas
activ
endonucleas
resolvas
cut
nick
heteroduplex
site
upon
reamplif
help
filter
error
commerci
enzymat
cocktail
erras
commonli
use
help
reduc
error
synthet
gene
well
error
reduct
greatli
reduc
cost
time
gene
synthesi
bring
error
rate
low
enough
gene
directli
use
function
assay
without
vivo
clone
sequenc
verif
recent
approach
leverag
ng
technolog
screen
select
perfect
sequenc
either
oligo
gene
level
matza
et
al
use
sequenc
roch
combin
robot
pickinplac
pipett
mechan
pull
read
perfect
sequenc
sequenc
array
use
oligo
synthet
gene
kim
et
al
also
use
mark
individu
molecul
random
tag
amplifi
construct
perfect
sequenc
approach
help
reduc
error
rate
although
still
suffer
sequenc
error
requir
expens
longread
platform
schwartz
et
al
use
illumina
sequenc
barcod
pull
perfect
sequenc
overcam
limit
length
sequenc
error
tagbas
consensussequenc
approach
three
approach
substanti
cut
error
rate
continu
improv
rapid
progress
dna
sequenc
technolog
ngsbase
errorcorrect
approach
also
especi
excit
librarybas
construct
synthesi
method
allow
correct
without
separ
gene
assembl
individu
reaction
larger
dna
assembl
method
produc
larger
assembl
combin
sequenceverifi
de
novosynthes
amplifi
genelength
fragment
seen
rapid
advanc
commerci
academ
system
allow
combin
librari
form
high
effici
fidel
reliabl
reason
low
reaction
cost
today
seamless
assembl
method
leav
behind
scar
assembl
junctionsinclud
ligas
cycl
reaction
gibson
assembl
seamless
ligat
clone
extract
yeast
assembl
circular
polymeras
extens
clone
sequenceand
ligationindepend
clone
golden
gate
othersar
routin
use
autom
academ
industri
set
method
also
use
gener
larg
multicompon
librari
littl
extra
effort
thu
de
novo
synthesi
applic
cost
error
associ
gener
genes
fragment
domin
requir
construct
larger
dna
assembl
emerg
applic
larg
de
novo
dna
synthesi
molecular
tool
one
first
largest
use
synthet
dna
develop
human
mous
short
hairpin
rna
librari
use
agil
oligo
pool
research
synthes
short
hairpin
rna
target
human
mous
gene
total
compris
mb
de
novo
sequenc
improv
length
ngsbase
screen
approach
greatli
expand
usag
applic
librari
oligo
pool
also
use
routin
target
captur
resequenc
exon
genom
region
interest
well
studi
genet
regulatori
mechan
genomewid
cpg
methyl
rna
edit
allelespecif
express
figur
comparison
report
error
rate
errorcorrect
techniqu
error
rate
includ
along
indic
oligo
sourc
errorcorrect
methodolog
start
error
rate
unreport
estim
error
rate
basi
oligo
sourc
assembl
method
open
circl
denot
start
error
rate
fill
circl
denot
error
rate
assembl
gene
two
fill
circl
denot
error
rate
error
correct
ssdna
singlestrand
dna
dsdna
doublestrand
dna
column
columnsynthes
oligo
array
microarraybas
oligo
pool
hyb
oligo
hybridizationbas
error
correct
seq
ngsbase
error
correct
lig
hightemperatur
ligationhybridizationbas
error
correct
nucleas
nucleasebas
error
correct
larman
et
al
peptid
use
mb
dna
identifi
autoimmun
target
patient
sampl
group
also
construct
ration
design
human
antibodi
librari
use
oligo
pool
optim
ng
analysi
similar
phagedisplay
method
use
profil
interact
pdz
domain
known
human
viral
protein
c
termini
warner
et
al
use
oligo
pool
construct
genomewid
barcod
knockout
overexpress
librari
e
coli
facilit
select
trait
interest
recent
two
group
leverag
cluster
regularli
interspac
short
palindrom
repeat
crispr
mediat
gene
target
combin
larg
oligo
pool
construct
comprehens
pool
barcod
knockout
librari
human
cell
line
molecular
tool
directli
enabl
avail
microarraybas
oligo
pool
expect
come
year
improv
length
qualiti
scale
librari
microarraybas
oligo
librari
also
use
help
uncov
structur
quantit
effect
regulatori
element
drive
express
one
earliest
exampl
patwardhan
et
al
use
oligo
pool
synthet
promot
mutant
bacteriophag
mammalian
pol
ii
core
promot
correspond
barcod
ng
readout
quantit
express
differ
map
import
base
core
activ
promot
later
schlabach
et
al
use
oligo
design
contain
array
transcript
factor
bind
site
screen
synthet
strong
promot
work
varieti
human
cell
line
recent
effort
focus
understand
structur
function
characterist
thousand
cisregulatori
sequenc
govern
transcript
translat
regulatori
process
mammalian
yeast
bacteri
system
come
year
ngsbase
methodolog
develop
measur
transcript
translat
epigenet
splice
gene
regulatori
phenomena
also
use
analyz
synthet
librari
goal
understand
sequenc
respons
causal
chang
process
use
engin
new
function
protein
engin
protein
engin
alway
benefit
improv
synthet
capabl
dna
shuffl
sitedirect
mutagenesi
lowcost
gene
synthesi
de
novo
synthesi
howev
provid
power
tool
engin
new
protein
function
take
advantag
comput
design
metagenom
inform
exampl
bayer
et
al
synthes
methyl
halid
transferas
enzym
found
metagenom
sequenc
divers
organ
show
larg
improv
enzymat
activ
anoth
exampl
kudla
et
al
quan
et
al
construct
character
librari
report
gene
gene
respect
studi
codon
usag
recent
group
use
oligo
pool
combin
multiplex
report
assay
construct
report
construct
measur
transcript
translat
rate
understand
ntermin
codon
bia
affect
protein
express
final
develop
deep
mutat
scan
techniqu
measur
structurefunct
relationship
multiplex
enabl
rapid
character
larg
design
synthet
gene
librari
synthesi
method
improv
genet
refactor
better
understand
engin
particular
genet
system
research
begun
redesign
de
novo
synthes
system
orthogon
welldefin
gene
sequenc
control
element
refactor
research
hope
defin
includ
known
element
pathway
simultan
disrupt
unknown
control
element
may
serv
better
start
point
improv
transplant
genet
system
earli
work
resynthes
first
kb
bacteriophag
refactor
surrog
separ
defin
individu
gene
control
element
show
result
phage
viabl
recent
bacteriophag
genom
refactor
help
improv
biolog
understand
use
temm
et
al
extend
approach
refactor
klebsiella
oxytoca
nitrogenfix
cluster
e
coli
remov
noncod
sequenc
elimin
nonessenti
gene
remov
transcript
factor
random
codon
place
gene
seven
operon
synthet
regulatori
element
govern
transcript
translat
refactor
system
reconstitut
function
albeit
reduc
product
level
improv
design
autom
assembl
refactor
segment
allow
reconstitut
wildtyp
product
level
final
lajoi
et
al
synthes
sequenceorthogon
variant
e
coli
essenti
gene
use
dna
microarray
select
function
order
explor
limit
genet
recod
studi
power
explor
regulatori
requir
genet
sequenc
requir
current
expens
de
novo
synthesi
methodolog
would
greatli
benefit
lowercost
gene
synthesi
engin
genet
network
metabol
pathway
mani
research
synthet
biolog
focus
build
optim
genet
network
control
cellular
behavior
metabol
pathway
chemic
product
although
mani
effort
focus
assembl
alreadi
exist
dna
myriad
combin
de
novo
synthesi
still
import
mainstay
becom
increasingli
improv
abil
design
measur
effect
assembl
pathway
instanc
build
larg
multicompon
system
number
orthogon
compon
becom
limit
largescal
studi
hundr
ten
thousand
regulatori
element
promot
ribosomebind
site
transcript
termin
e
coli
usual
use
de
novo
synthesi
design
cull
natur
design
sequenc
voigt
lab
also
appli
synthet
metagenom
part
mine
find
librari
orthogon
repressor
synthet
gene
transcript
factor
synthet
gene
thu
genet
network
pathway
engin
system
synthet
biolog
get
larger
studi
move
new
organ
increas
relianc
de
novo
dna
synthesi
gener
requisit
system
compon
beyond
viral
genom
seri
studi
venter
institut
design
built
assembl
transplant
fulli
synthet
bacteri
genom
encod
viabl
organ
effort
increas
exampl
design
synthesi
viabil
synthet
design
yeast
chromosom
arm
shown
dymond
et
al
work
fulli
synthet
yeast
genom
ongo
dna
nanotechnolog
chemic
polym
dna
sever
uniqu
properti
make
intrigu
first
compact
helic
form
simpl
basepair
rule
doublestrand
dna
allow
us
consid
dna
technolog
reliabl
posit
atom
threedimension
space
nanomet
resolut
emerg
dna
origami
singlestrand
tile
form
complex
shape
use
research
tackl
problem
materi
therapeut
basepair
strandinvas
properti
dna
also
allow
research
explor
interest
inform
process
comput
capabl
use
small
librari
oligo
final
direct
encod
digit
inform
dna
sequenc
recent
shown
outpac
technolog
data
densiti
three
dimens
still
earli
stage
field
har
advanc
oligopool
synthesi
applic
allow
research
test
order
magnitud
design
hypothes
given
requisit
invest
cost
gene
synthesi
might
expect
attain
today
cost
gene
synthesi
order
cost
columnsynthes
oligo
use
assembl
gene
synthesi
transit
arraybas
oligo
prima
faci
reason
cost
could
fall
order
magnitud
par
cost
oligo
pool
per
bp
benefit
would
like
dramat
product
gain
due
ng
test
genet
hypothes
would
becom
simpl
design
analys
allow
howev
larg
privat
invest
drove
massiv
drop
cost
integr
circuit
dna
sequenc
larg
motiv
reason
expect
broadbas
consumerlevel
use
processor
everi
pocket
genom
sequenc
everi
person
wherea
potenti
larger
market
stand
benefit
cheap
gene
synthesi
includ
agricultur
chemic
enzym
materi
medicin
synthet
dna
serv
research
tool
ultim
product
possibl
except
dna
nanotechnolog
largerscal
synthet
biolog
effort
help
increas
demand
suffici
spur
invest
even
academ
research
lab
downstream
cost
test
individu
biolog
construct
function
often
far
expens
cost
synthet
construct
thu
reduct
gene
synthesi
cost
tremend
affect
throughput
scale
current
experiment
workflow
howev
type
experi
conduct
might
also
significantli
chang
one
data
point
consid
occur
decad
ago
microarray
first
leverag
cheap
oligo
pool
although
initi
report
use
pool
plugin
replac
columnsynthes
oligo
research
quickli
adapt
increas
synthet
capac
use
power
bioinformat
tool
design
larg
librari
synthet
oligo
ngsbase
multiplex
assay
measur
function
consequ
simultan
recent
led
mani
fruit
experi
scale
year
ago
would
unimagin
individu
investig
likewis
cheap
gene
synthesi
like
chang
use
synthet
gene
develop
power
design
tool
librari
gene
pathway
genom
well
cheap
multiplex
assay
measur
select
function
new
experiment
paradigm
could
engend
far
greater
use
synthet
gene
current
imagin
today
initi
progress
describ
review
warrant
optim
hope
enough
demand
invest
bring
larg
advanc
abil
design
build
test
analyz
biolog
hypothes
design
focu
synthet
biolog
